| Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer C Hu, SN Hart, EC Polley, R Gnanaolivu, H Shimelis, KY Lee, J Lilyquist, ... Jama 319 (23), 2401-2409, 2018 | 525 | 2018 |
| Non-V600BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer JC Jones, LA Renfro, HO Al-Shamsi, AB Schrock, A Rankin, BY Zhang, ... Journal of Clinical Oncology 35 (23), 2624-2630, 2017 | 366 | 2017 |
| Colorectal cancer E Dekker, PM Tanis, PJ, Vleugels, JLA, Kasi, MB Wallace Lancet 394 (10207), 1467-1480, 2019 | 335 | 2019 |
| Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan M Kassi, M Kassi, AK Afghan, R Rehman, PM Kasi PLoS neglected tropical diseases 2 (10), e259, 2008 | 210 | 2008 |
| Validation of microsatellite instability detection using a comprehensive plasma-based genotyping panel J Willis, MI Lefterova, A Artyomenko, PM Kasi, Y Nakamura, K Mody, ... Clinical Cancer Research 25 (23), 7035-7045, 2019 | 204 | 2019 |
| Clinical review: Serious adverse events associated with the use of rituximab-a critical care perspective PM Kasi, HA Tawbi, CV Oddis, HS Kulkarni Critical Care 16, 1-10, 2012 | 195 | 2012 |
| Rising proportion of young individuals with rectal and colon cancer PM Kasi, F Shahjehan, JJ Cochuyt, Z Li, DT Colibaseanu, A Merchea Clinical colorectal cancer 18 (1), e87-e95, 2019 | 159 | 2019 |
| COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials A Desai, JF Gainor, A Hegde, AM Schram, G Curigliano, S Pal, SV Liu, ... Nature reviews Clinical oncology 18 (5), 313-319, 2021 | 156 | 2021 |
| Molecular biomarkers in the personalized treatment of colorectal cancer FA Sinicrope, K Okamoto, PM Kasi, H Kawakami Clinical Gastroenterology and Hepatology 14 (5), 651-658, 2016 | 130 | 2016 |
| Coping styles in patients with anxiety and depression PM Kasi, HA Naqvi, AK Afghan, T Khawar, FH Khan, UZ Khan, ... International Scholarly Research Notices 2012 (1), 128672, 2012 | 128 | 2012 |
| Using circulating tumor DNA in colorectal cancer: current and evolving practices M Malla, JM Loree, PM Kasi, AR Parikh Journal of Clinical Oncology 40 (24), 2846-2857, 2022 | 126 | 2022 |
| RESEARCH: What, Why and How? A Treatise from Researchers to Researchers PM Kasi AuthorHouse™ 1, 327, 2009 | 115* | 2009 |
| Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma AH Zaidi, LA Kelly, RE Kreft, M Barlek, AN Omstead, D Matsui, NH Boyd, ... BMC cancer 16, 1-10, 2016 | 109 | 2016 |
| Acute health effects of the Tasman Spirit oil spill on residents of Karachi, Pakistan NZ Janjua, PM Kasi, H Nawaz, SZ Farooqui, UB Khuwaja, SN Jafri, ... BMC public health 6, 1-11, 2006 | 104 | 2006 |
| Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label … JH Strickler, A Cercek, S Siena, T André, K Ng, E Van Cutsem, C Wu, ... The Lancet Oncology 24 (5), 496-508, 2023 | 89 | 2023 |
| Folate receptor alpha peptide vaccine generates immunity in breast and ovarian cancer patients KR Kalli, MS Block, PM Kasi, CL Erskine, TJ Hobday, A Dietz, D Padley, ... Clinical Cancer Research 24 (13), 3014-3025, 2018 | 87 | 2018 |
| Determining the risk factors and prevalence of osteoporosis using quantitative ultrasonography in Pakistani adult women M Fatima, H Nawaz, M Kassi, R Rehman, PM Kasi, M Kassi, AK Afghan, ... Singapore medical journal 50 (1), 20, 2009 | 83 | 2009 |
| Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study PM Kasi, D Kotani, M Cecchini, K Shitara, A Ohtsu, RK Ramanathan, ... BMC cancer 16, 1-7, 2016 | 73 | 2016 |
| Epilepsy: public knowledge and attitude in a slum area of Karachi, Pakistan M Shafiq, M Tanwir, A Tariq, PM Kasi, M Zafar, A Saleem, R Rehman, ... Seizure 16 (4), 330-337, 2007 | 72 | 2007 |
| Impact of circulating tumor DNA–based detection of molecular residual disease on the conduct and design of clinical trials for solid tumors PM Kasi, G Fehringer, H Taniguchi, N Starling, Y Nakamura, D Kotani, ... JCO Precision Oncology 6, e2100181, 2022 | 68 | 2022 |
Faisal ShahjehanConemaugh Health SystemVerified email at conemaugh.org